GNI  Group Ltd. Logo

GNI Group Ltd.

2160 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町二丁目2番2号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GNI Group Ltd. is a Japanese biopharmaceutical company focused on developing innovative therapies to address unmet medical needs. The company is involved in the research and development of novel treatments, particularly in the fields of oncology and rare diseases, leveraging advanced biotechnology. GNI Group engages in strategic partnerships and collaborations to enhance its product pipeline and accelerate drug development. With a commitment to improving patient outcomes, the company aims to deliver cutting-edge solutions that can transform healthcare. Recent announcements include participation in conferences and the launch of new therapies, reflecting GNI's active role in the global biopharmaceutical landscape.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GNI Group Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-23 09:00
Regulatory News Service
臨時報告書
Japanese 32.7 KB
2025-03-31 09:00
Regulatory News Service
確認書
Japanese 8.2 KB
2025-03-31 09:00
Regulatory News Service
内部統制報告書-第24期(2024/01/01-2024/12/31)
Japanese 22.2 KB
2025-03-31 09:00
Annual Report
有価証券報告書-第24期(2024/01/01-2024/12/31)
Japanese 1.2 MB
2025-03-28 03:30
Regulatory News Service
臨時報告書
Japanese 21.6 KB
2024-08-14 10:08
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2024-08-14 09:26
Interim Report
半期報告書-第24期(2024/01/01-2024/12/31)
Japanese 301.9 KB
2024-08-14 09:26
Regulatory News Service
確認書
Japanese 10.0 KB
2024-07-02 08:00
Regulatory News Service
訂正報告書(大量保有報告書・変更報告書)
Japanese 51.9 KB
2024-06-28 09:00
Major Shareholding Notification
大量保有報告書
Japanese 52.6 KB
2024-05-30 09:30
Regulatory News Service
臨時報告書
Japanese 32.3 KB
2024-05-15 09:02
Quarterly Report
四半期報告書-第24期第1四半期(2024/01/01-2024/03/31)
Japanese 255.3 KB
2024-05-15 09:02
Regulatory News Service
確認書
Japanese 10.0 KB
2024-03-29 02:00
Regulatory News Service
臨時報告書
Japanese 21.7 KB
2024-03-28 08:32
Regulatory News Service
臨時報告書
Japanese 19.1 KB

Automate Your Workflow. Get a real-time feed of all GNI Group Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GNI Group Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK